I-Veyong Pharma ibambe umncintiswano wolwazi lwesiko lebhizinisi

Ukuze kuthuthukiswe kangcono ukusatshalaliswa kwesiko lebhizinisi lika-Limin, kugqugquzelwe ukuqaliswa ngempumelelo kwesiko lebhizinisi nolwazi lokuthuthukiswa kwenkampani, ukuhlola ukufundwa kwesiko lebhizinisi, ukukhangisa nokusebenzisa imiphumela, nokwenza isiko lebhizinisi lifakwe ngaphakathi enhliziyweni futhi libe ngaphandle ekusebenzeni.Ngemvume yabaholi beqembu, hlela futhi wenze imisebenzi yokufunda nokuhlola ku-inthanethi yesiko lebhizinisi ngaphakathi kwezinkampani zeqembu.

Ntambama yangomhla ziyisi-6 kuJulayi, i-Veyong Pharma yabamba umncintiswano wolwazi lwezamasiko enkampani onendikimba ethi “Amasiko ahola isifiso sokuqala, futhi egxile ekudaleni umbono”.Bangu-21 sebebonke abangenele lo mqhudelwano abavela emaqenjini angu-7 avela ezinkundleni zokucobelelana ngolwazi neminyango eyahlukene ababambe iqhaza kulo mcimbi.Umncintiswano wolwazi ubushubile futhi unomdlandla futhi uthakazelisa, ohlanganise ngokugcwele umdlandla kanye nesinyathelo sokufunda sawo wonke umuntu.Esinyathelweni esilandelayo, inkampani izophinde isebenzise umqondo wesiko lenkampani, ihlakulele abantu, abantu abafudumele ngamasiko, futhi iqoqe abantu ngesiko;vumela isiko lebhizinisi linikeze amandla angokomoya aqinile nokusekelwa kwamasiko ekuthuthukisweni kwekhwalithi ephezulu yenkampani.

I-Veyong ibambelela endleleni yentuthuko "yokuhlanganisa i-R&D ezimele, ukuthuthukiswa ngokubambisana kanye nesingeniso sobuchwepheshe", ngokuqhubekayo ithuthukisa imikhiqizo emisha futhi ithuthukise imikhiqizo emidala ukuze inikeze amakhasimende ulwazi lwemithi olusebenza kahle kakhudlwana.

I-Veyong ithatha “ukuba nekhono ku-biotechnology, ukudala impilo esezingeni eliphezulu” njengomgomo, ilwela ukuba uhlobo olubaluleke kakhulu lwemithi yezilwane, futhi ibheke ngabomvu ukubambisana okusebenzayo namakhasimende omhlabaivermectin, i-tiamulin hydrogen fumarate, i-oxytetracycline hydrochloridekanye namalungiselelo.